Table 2 Clinicopathological features of 19 CC samples used for microarray analysis.
Sample No | Age/Sex | Loca tion | Size (cm) | T | N | M | Stage | Gross appearance | Differentiation | Sub-class | Comment |
|---|---|---|---|---|---|---|---|---|---|---|---|
1 (CC-GHS) | 68/F | L | 8.7 × 5.4 | 3 | 1 | 0 | IVA | MF | PD | A |  |
2 (CC-CYS) | 57/M | L | NA | 3 | 1 | 0 | IVA | MF +PDI | MD | A | Â |
3 (CC-LJS) | 42/M | A | NA | 1 | 0 | 0 | I | ID | WD | B | Intraductal papillary |
4 (CC-BJP) | 62/M | P | 7.8 × 5.6 | 1 | 0 | 0 | I | ID | WD | B | Intraductal papillary |
5 (CC-HSR) | 66/M | AP | 7.3 × 6 | 2 | 0 | 0 | II | MF | MD | B |  |
6 (CC-HSW) | 59/M | AP | 9 × 6.8 | 2 | 0 | 0 | II | MF | MD | B |  |
7 (CC-CSB) | 60/M | L | 4 × 4.5 | 3 | 0 | 0 | III | MF | MD | B |  |
8 (CC-SJS) | 71/M | A | 2.1 × 1.9 | 1 | 0 | 0 | II | MF | WD | B |  |
9 (CC-HDS) | 63/M | CBD | 1.1 × 0.9 | 1 | 1 | 1 | IVB | ID | MD | B |  |
10 (CC-KHC) | 47/M | L | 14 × 10 | 4 | 0 | 0 | IVA | MF | PD | C |  |
11 (CC-LHG) | 42/M | L | 5.6 × 3.9 | 3 | 1 | 0 | IVA | MF | PD | C | Combined with HCC |
12 (CC-LSH) | 40/F | P | 8.6 × 4 | 2 | 0 | 1 | IVB | MF | PD | C | Combined with HCC |
13 (CC-KHS) | 70/F | L | 8.5 × 4.8 | 3 | 0 | 1 | IVB | MF +PDI | PD | C | Combined with HCC |
14 (CC-LMS) | 38/F | AP | 5 × 3.7 | 4 | 0 | 1 | IVB | MF | PD | C | Combined with HCC |
15 (CC-KJA) | 39/F | LP | 6 × 5 | 4 | 0 | 0 | IVA | MF | MD | C | Combined with HCC |
16 (CC-JSJ) | 64/M | L | 0.5 × 0.5 | 2 | 0 | 1 | IVB | ID | PD | C |  |
17 (CC-YCU) | 53/M | L | 4.3 × 2.1 | 3 | 1 | 0 | IVA | MF | MD | C |  |
18 (CC-GMG) | 50/M | L | 7 × 3.5 | 2 | 0 | 0 | II | MF | MD | C |  |
19 (CC-BSD) | 67/M | L | 2.9 × 2.7 | 4 | 0 | 0 | IVA | MF+P야 | PD | C |  |